Target
Complement factor D
Ligand
BDBM302893
Substrate
n/a
Meas. Tech.
Inhibition Assay
IC50
<1000±n/a nM
Citation
 Wiles, JAPhadke, ASDeshpande, MAgarwal, AChen, DGadhachanda, VRHashimoto, APais, GWang, QWang, X Amino compounds for treatment of medical disorders US Patent  US10660876 Publication Date 5/26/2020 
Target
Name:
Complement factor D
Synonyms:
Adipsin | C3 convertase activator | CFAD_HUMAN | CFD | DF | PFD | Properdin factor D
Type:
Protein
Mol. Mass.:
27039.19
Organism:
Homo sapiens (Human)
Description:
P00746
Residue:
253
Sequence:
MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA
  
Inhibitor
Name:
BDBM302893
Synonyms:
1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(5- cyanopyrimidin-2- ylamino)-1H- indazole-3- carboxamide | US10660876, Cmpd No. 13 | US9598446, Compound 13
Type:
Small organic molecule
Emp. Form.:
C32H24ClF2N9O3
Mol. Mass.:
656.041
SMILES:
NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(Nc3ncc(cn3)C#N)cc12 |r|
Structure:
Search PDB for entries with ligand similarity: